233 results on '"Zuur, Charlotte L."'
Search Results
2. Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors
3. CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors
4. Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
5. A pan-cancer analysis of the microbiome in metastatic cancer
6. Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma
7. Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgery
8. Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
9. The MARIANE-trial: Multicenter phase 1b/2 trial testing safety and efficacy of neoadjuvant intradermal ipilimumab and nivolumab in high-risk stage II melanoma.
10. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
11. Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
12. Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: A systematic review and meta-analysis
13. [18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma
14. ASO Visual Abstract: Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma
15. Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
16. Therapeutic neck dissection in head and neck melanoma patients: Comparing extent of surgery and clinical outcome in two cohorts
17. Talimogene laherparepvec monotherapy for head and neck melanoma patients
18. T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model
19. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas
20. The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy.
21. Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial
22. Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
23. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma
24. Disease course after the first recurrence of head and neck squamous cell carcinoma following (chemo)radiation
25. Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair
26. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
27. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation
28. Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity
29. Dual Immune Checkpoint Blockade Induces Analogous Alterations in the Dysfunctional CD8+ T-cell and Activated Treg Compartment
30. Optimizing Wound Care after Surgery of the Head and Neck: A Review of Dressing Materials.
31. Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors
32. Abstract 5786: Spatial relationships in the tumor microenvironment predict response to immune checkpoint inhibitors in urothelial and head and neck cancer
33. Abstract 2281: Dual immune checkpoint blockade induces analogous alterations in the dysfunctional CD8+ T cell and activated Treg compartment
34. Optimizing Wound Care after Surgery of the Head and Neck: A Review of Dressing Materials
35. Trends in Incidence and Survival of 1496 Patients with Mucosal Melanoma in The Netherlands (1990–2019)
36. Baseline ultrasound and FDG‐PET/CT imaging in Merkel cell carcinoma
37. Quantitative Diffusion-Weighted Imaging Analyses to Predict Response to Neoadjuvant Immunotherapy in Patients with Locally Advanced Head and Neck Carcinoma
38. Talimogene laherparepvec monotherapy for head and neck melanoma patients
39. Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma
40. The NADINA trial: A multicenter, randomised, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resectable stage III melanoma.
41. Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma:Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
42. Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients:A systematic review and meta-analysis
43. Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma
44. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
45. Baseline ultrasound and FDG‐PET/CT imaging in Merkel cell carcinoma.
46. Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
47. [18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma
48. Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes
49. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy
50. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: A systematic review of the literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.